Prof. Dr. med. Jens Kuhle

Schindler, P., Bellmann-Strobl, J., Kuhle, J., Wildemann, B., Jarius, S., Paul, F., & Ruprecht, K. (2024). Longitudinal change of serum NfL as disease activity biomarker candidate in MOGAD: A descriptive cohort study. Multiple Sclerosis and Related Disorders, 88. https://doi.org/10.1016/j.msard.2024.105729

Zivadinov, R., Jakimovski, D., Burnham, A., Kuhle, J., Weinstock, Z., Wicks, T. R., Ramanathan, M., Sciortino, T., Ostrem, M., Suchan, C., Dwyer, M. G., Reilly, J., Bergsland, N., Schweser, F., Kennedy, C., Young-Hong, D., Eckert, S., Hojnacki, D., Benedict, R. H. B., & Weinstock-Guttman, B. (2024). Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study. Journal of Neurology, 271(8), 4949–4962. https://doi.org/10.1007/s00415-024-12420-2

Fischbach, F., Richter, J., Pfeffer, L. K., Fehse, B., Berger, S. C., Reinhardt, S., Kuhle, J., Badbaran, A., Rathje, K., Gagelmann, N., Borie, D., Seibel, J., Ayuk, F., Friese, M. A., Heesen, C., & Kröger, N. (2024). CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis. Med, 5(6), 550–558. https://doi.org/10.1016/j.medj.2024.03.002

Maatta, L. L., Andersen, S. T., Parkner, T., Hviid, C. V. B., Bjerg, L., Kural, M. A., Charles, M., Søndergaard, E., Kuhle, J., Tankisi, H., Witte, D. R., & Jensen, T. S. (2024). Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark. Diabetes Care, 47(6), 986–994. https://doi.org/10.2337/dc23-2208

Sharmin, S., Roos, I., Malpas, C. B., Iaffaldano, P., Simone, M., Filippi, M., Kubala Havrdova, E., Ozakbas, S., Brescia Morra, V., Alroughani, R., Zaffaroni, M., Patti, F., Eichau, S., Salemi, G., Di Sapio, A., Inglese, M., Portaccio, E., Trojano, M., Amato, M. P., et al. (2024). Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries. The Lancet Child and Adolescent Health, 8(5), 348–357. https://doi.org/10.1016/S2352-4642(24)00047-6

Spelman, T., Eichau, S., Alroughani, R., Ozakbas, S., Khoury, S. J., Patti, F., Kubala Havrdova, E., Boz, C., Terzi, M., Kuhle, J., Grammond, P., Lechner-Scott, J., Gray, O., Amato, M. P., Laureys, G., Shaygannejad, V., Hyde, R., Wang, H., Bozin, I., et al. (2024). Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 10(2). https://doi.org/10.1177/20552173241247182

Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1- A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in Multiple Sclerosis: a study protocol for a randomized clinical trial [Posted-content]. In medRxiv. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.03.22.24304720

Geis, T., Gutzeit, S., Disse, S., Kuhle, J., Fouzas, S., & Wellmann, S. (2024). Neurofilament Light Chain Concentration in Cerebrospinal Fluid in Children with Acute Nontraumatic Neurological Disorders. Children, 11(3). https://doi.org/10.3390/children11030360

Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Cagol, Alessandro, Lu, Po-Jui, Schaedelin, Sabine A., Franz, Jonas, Barakovic, Muhamed, Rahmanzadeh, Reza, Dechent, Peter, Nair, Govind, Brück, Wolfgang, Kuhle, Jens, Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2024). Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis [Journal-article]. Neurology, 102(3). https://doi.org/10.1212/wnl.0000000000207966

Rusche, Thilo, Yaldizli, Özgür, Galbusera, Riccardo, Mutke, Matthias, Halter, Jörg P, Lieb, Johanna, Matteazzi, Francesca, Stelmes, Anne, Bittner, Jan, Grzonka, Pascale, Frank, Nicole, Cordier, Dominik, Hench, Jürgen, Frank, Stephan, Hirsch, Hans H, Fischer, Urs, Kuhle, Jens, Sutter, Raoul, Rüegg, Stephan, & Fisch, Urs. (2024). Anti-GABAA receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia [Journal-article]. The Lancet, 403(10425), 469–470. https://doi.org/10.1016/s0140-6736(23)02831-3

Linnemann, Christoph, Wilke, Carlo, Mengel, David, Zetterberg, Henrik, Heller, Carolin, Kuhle, Jens, Bouzigues, Arabella, Russell, Lucy L, Foster, Phoebe H, Ferry-Bolder, Eve, Van Swieten, John Cornelis, Jiskoot, Lize C, Seelaar, Harro, Moreno, Fermin, Borroni, Barbara, Sánchez-Valle, Raquel, Galimberti, Daniela, Laforce, Robert, Graff, Caroline, et al. (2024). NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study [Journal-article]. Journal of Neurology, Neurosurgery & Psychiatry, jnnp–2023. https://doi.org/10.1136/jnnp-2023-332464

Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Müller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS [Journal-article]. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768

Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Müller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS [Journal-article]. Neurology, 102(1). https://doi.org/10.1212/wnl.0000000000207768

Pontillo, G., Prados, F., Colman, J., Kanber, B., Abdel-Mannan, O., Al-Araji, S., Ballenberg, B., Bianchi, A., Bisecco, A., Brownlee, W., Brunetti, A., Cagol, A., Calabrese, M., Castellaro, M., Christensen, R., Cocozza, S., Colato, E., Collorone, S., Cortese, R., et al. (2024). Disentangling neurodegeneration from ageing in multiple sclerosis: the brain-predicted disease duration gap [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.01.02.23300497

Abdelhak, Ahmed, Antweiler, Kai, Kowarik, Markus C., Senel, Makbule, Havla, Joachim, Zettl, Uwe K., Kleiter, Ingo, Skripuletz, Thomas, Haarmann, Axel, Stahmann, Alexander, Huss, Andre, Gingele, Stefan, Krumbholz, Markus, Benkert, Pascal, Kuhle, Jens, Friede, Tim, Ludolph, Albert C., Ziemann, Ulf, Kümpfel, Tania, & Tumani, Hayrettin. (2024). Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis. Annals of Clinical and Translational Neurology, 11, 477–485. https://doi.org/10.1002/acn3.51969

Barakovic, Muhamed, Weigel, Matthias, Cagol, Alessandro, Schaedelin, Sabine, Galbusera, Riccardo, Lu, Po-Jui, Chen, Xinjie, Melie-Garcia, Lester, Ocampo-Pineda, Mario, Bahn, Erik, Stadelmann, Christine, Palombo, Marco, Kappos, Ludwig, Kuhle, Jens, Magon, Stefano, & Granziera, Cristina. (2024). A novel imaging marker of cortical “cellularity” in multiple sclerosis patients [Journal-article]. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-60497-6

Cagol, Alessandro, Benkert, Pascal, Melie-Garcia, Lester, Schaedelin, Sabine A., Leber, Selina, Tsagkas, Charidimos, Barakovic, Muhamed, Galbusera, Riccardo, Lu, Po-Jui, Weigel, Matthias, Ruberte, Esther, Radue, Ernst-Wilhelm, Yaldizli, Özgür, Oechtering, Johanna, Lorscheider, Johannes, D’Souza, Marcus, Fischer-Barnicol, Bettina, Muller, Stefanie, Achtnichts, Lutz, et al. (2024). Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. Neurology, 102. https://doi.org/10.1212/wnl.0000000000207768

Cagol, Alessandro, Ocampo-Pineda, Mario, Lu, Po-Jui, Weigel, Matthias, Barakovic, Muhamed, Melie-Garcia, Lester, Chen, Xinjie, Lutti, Antoine, Calabrese, Pasquale, Kuhle, Jens, Kappos, Ludwig, Sormani, Maria Pia, & Granziera, Cristina. (2024). Advanced Quantitative MRI Unveils Microstructural Thalamic Changes Reflecting Disease Progression in Multiple Sclerosis [Journal-article]. Neurology: Neuroimmunology and NeuroInflammation, 11(6). https://doi.org/10.1212/NXI.0000000000200299

Callegari, Ilaria, Oechtering, Johanna, Schneider, Mika, Perriot, Sylvain, Mathias, Amandine, Voortman, Margarete M., Cagol, Alessandro, Lanner, Ulrike, Diebold, Martin, Holdermann, Sebastian, Kreiner, Victor, Becher, Burkhard, Granziera, Cristina, Junker, Andreas, Pasquier, Renaud Du, Khalil, Michael, Kuhle, Jens, Kappos, Ludwig, Sanderson, Nicholas S.R., & Derfuss, Tobias. (2024). Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5. Brain, 147, 839–848. https://doi.org/10.1093/brain/awad424

Chalkou, Konstantina, Hamza, Tasnim, Benkert, Pascal, Kuhle, Jens, Zecca, Chiara, Simoneau, Gabrielle, Pellegrini, Fabio, Manca, Andrea, Egger, Matthias, & Salanti, Georgia. (2024). Combining randomized and non-randomized data to predict heterogeneous effects of competing treatments. Research Synthesis Methods, 15, 641–656. https://doi.org/10.1002/jrsm.1717

Fissolo, Nicolás, Benkert, Pascal, Sastre-Garriga, Jaume, Mongay-Ochoa, Neus, Vilaseca-Jolonch, Andreu, Llufriu, Sara, Blanco, Yolanda, Hegen, Harald, Berek, Klaus, Perez-Miralles, Francisco, Rejdak, Konrad, Villar, Luisa M., Monreal, Enric, Alvarez-Lafuente, Roberto, Soylu, Onder K., Abdelhak, Ahmed, Bachhuber, Franziska, Tumani, Hayrettin, Martínez-Yélamos, Sergio, et al. (2024). Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 95, 410–418. https://doi.org/10.1136/jnnp-2023-332251

Freedman, Mark S., Gnanapavan, Sharmilee, Booth, Ronald A., Calabresi, Peter A., Khalil, Michael, Kuhle, Jens, Lycke, Jan, & Olsson, Tomas. (2024). Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management. eBioMedicine, 101. https://doi.org/10.1016/j.ebiom.2024.104970

Galbusera, Riccardo, Bahn, Erik, Weigel, Matthias, Cagol, Alessandro, Lu, Po-Jui, Schaedelin, Sabine A., Franz, Jonas, Barakovic, Muhamed, Rahmanzadeh, Reza, Dechent, Peter, Nair, Govind, Brück, Wolfgang, Kuhle, Jens, Kappos, Ludwig, Stadelmann, Christine, & Granziera, Cristina. (2024). Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis. Neurology, 102, e207966. https://doi.org/10.1212/wnl.0000000000207966

Hermesdorf, Marco, Wulms, Niklas, Maceski, Aleksandra, Leppert, David, Benkert, Pascal, Wiendl, Heinz, Kuhle, Jens, & Berger, Klaus. (2024). Serum neurofilament light and white matter characteristics in the general population: a longitudinal analysis. GeroScience, 46, 463–472. https://doi.org/10.1007/s11357-023-00846-x

Hirt, Julian, Dembowska, Kinga, Woelfle, Tim, Axfors, Cathrine, Granziera, Cristina, Kuhle, Jens, Kappos, Ludwig, Hemkens, Lars G., & Janiaud, Perrine. (2024). Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis. Journal of Neurology. https://doi.org/10.1007/s00415-024-12366-5

Hirt, Julian, Janiaud, Perrine, Düblin, Pascal, Nicoletti, Giovanni Jacopo, Dembowska, Kinga, Nguyen, Thao Vy Thi, Woelfle, Tim, Axfors, Cathrine, Yaldizli, Özgür, Granziera, Cristina, Kuhle, Jens, Kappos, Ludwig, & Hemkens, Lars G. (2024). Use of pragmatic randomized trials in multiple sclerosis: A systematic overview. Multiple Sclerosis Journal, 30, 463–478. https://doi.org/10.1177/13524585231221938

Janiaud, Perrine, Zecca, Chiara, Salmen, Anke, Benkert, Pascal, Schädelin, Sabine, Orleth, Annette, Demuth, Lilian, Maceski, Aleksandra Maleska, Granziera, Cristina, Oechtering, Johanna, Leppert, David, Derfuss, Tobias, Achtnichts, Lutz, Findling, Oliver, Roth, Patrick, Lalive, Patrice, Uginet, Marjolaine, Müller, Stefanie, Pot, Caroline, et al. (2024). MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial. Trials, 25. https://doi.org/10.1186/s13063-024-08454-6

Kagerer, Sonja M., Awasthi, Swapnil, Ripke, Stephan, Maceski, Aleksandra, Benkert, Pascal, Fall, Aïda B., Riederer, Peter, Fischer, Peter, Walitza, Susanne, Grünblatt, Edna, Kuhle, Jens, & Unschuld, Paul G. (2024). Polygenic risk for Alzheimer’s disease is associated with neuroaxonal damage before onset of clinical symptoms. Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 16. https://doi.org/10.1002/dad2.12504

Khalil, Michael, Teunissen, Charlotte E., Lehmann, Sylvain, Otto, Markus, Piehl, Fredrik, Ziemssen, Tjalf, Bittner, Stefan, Sormani, Maria Pia, Gattringer, Thomas, Abu-Rumeileh, Samir, Thebault, Simon, Abdelhak, Ahmed, Green, Ari, Benkert, Pascal, Kappos, Ludwig, Comabella, Manuel, Tumani, Hayrettin, Freedman, Mark S., Petzold, Axel, et al. (2024). Neurofilaments as biomarkers in neurological disorders — towards clinical application. Nature Reviews Neurology, 20, 269–287. https://doi.org/10.1038/s41582-024-00955-x

Kuhle, J. (2024). Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysis. Therapeutic Advances in Neurological Disorders, 17. https://doi.org/10.1177/17562864241239101

Linnemann, Christoph, Wilke, Carlo, Mengel, David, Zetterberg, Henrik, Heller, Carolin, Kuhle, Jens, Bouzigues, Arabella, Russell, Lucy L., Foster, Phoebe H., Ferry-Bolder, Eve, Van Swieten, John Cornelis, Jiskoot, Lize C., Seelaar, Harro, Moreno, Fermin, Borroni, Barbara, Sánchez-Valle, Raquel, Galimberti, Daniela, Laforce, Robert Jr, Graff, Caroline, et al. (2024). NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study. Journal of Neurology, Neurosurgery and Psychiatry, null. https://doi.org/10.1136/jnnp-2023-332464

Montalban, Xavier, Piasecka-Stryczynska, Karolina, Kuhle, Jens, Benkert, Pascal, Arnold, Douglas L, Weber, Martin S, Seitzinger, Andrea, Guehring, Hans, Shaw, Jamie, Tomic, Davorka, Hyvert, Yann, Harlow, Danielle E, Dyroff, Martin, & Wolinsky, Jerry S. (2024). Efficacy and safety results after >3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study. Multiple Sclerosis Journal, 30, 558–570. https://doi.org/10.1177/13524585241234783

Dekeyser, C., Hautekeete, M., Cambron, M., Van Pesch, V., Patti, F., Kuhle, J., Khoury, S., Lechner Scott, J., Gerlach, O., Lugaresi, A., Maimone, D., Surcinelli, A., Grammond, P., Kalincik, T., Habek, M., Willekens, B., Macdonell, R., Lalive, P., Csepany, T., et al. (2024). Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study [Journal-article]. Journal of Neurology, Neurosurgery and Psychiatry, jnnp–2023. https://doi.org/10.1136/jnnp-2023-333307

Müller, Jannis, Roos, Izanne, Kalincik, Tomas, Lorscheider, Johannes, Galli, Edoardo, Benkert, Pascal, Schädelin, Sabine, Sharmin, Sifat, Einsiedler, Maximilian, Hänni, Peter, Schmid, Jürg, Kuhle, Jens, Derfuss, Tobias, Granziera, Cristina, Ziemssen, Tjalf, Siepmann, Timo, & Yaldizli, Özgür. (2024). Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis. Brain and Behavior, 14. https://doi.org/10.1002/brb3.3498

Queissner, R., Buchmann, A., Demjaha, R., Tafrali, C., Benkert, P., Kuhle, J., Jerkovic, A., Dalkner, N., Fellendorf, F., Birner, A., Platzer, M., Tmava-Berisha, A., Maget, A., Stross, T., Lenger, M., Häussl, A., Khalil, M., & Reininghaus, E. (2024). Serum neurofilament light as a potential marker of illness duration in bipolar disorder. Journal of Affective Disorders, 350, 366–371. https://doi.org/10.1016/j.jad.2024.01.088

Roos, I., Sharmin, S., Malpas, C., Ozakbas, S., Lechner-Scott, J., Hodgkinson, S., Alroughani, R., Eichau Madueño, S., Boz, C., van der Walt, A., Butzkueven, H., Buzzard, K., Skibina, O., Foschi, M., Grand’Maison, F., John, N., Grammond, P., Terzi, M., Prévost, J., et al. (2024). Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585241267211

Rusche, Thilo, Yaldizli, Özgür, Galbusera, Riccardo, Mutke, Matthias, Halter, Jörg P, Lieb, Johanna, Matteazzi, Francesca, Stelmes, Anne, Bittner, Jan, Grzonka, Pascale, Frank, Nicole, Cordier, Dominik, Hench, Jürgen, Frank, Stephan, Hirsch, Hans H, Fischer, Urs, Kuhle, Jens, Sutter, Raoul, Rüegg, Stephan, & Fisch, Urs. (2024). Anti-GABA A receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia. The Lancet, 403, 469–470. https://doi.org/10.1016/s0140-6736(23)02831-3

Sehr, Tony, Akgün, Katja, Benkert, Pascal, Kuhle, Jens, Ziemssen, Tjalf, & Brandt, Moritz D. (2024). Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance. Journal of Sleep Research. https://doi.org/10.1111/jsr.14164

Signori, Alessio, Ponzano, Marta, Kalincik, Tomas, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva Kubala, Alroughani, Raed, Patti, Francesco, Kuhle, Jens, Izquierdo, Guillermo, Eichau, Sara, Yamout, Bassem, Khoury, Samia Joseph, Karabudak, Rana, Grammond, Pierre, Duquette, Pierre, Roos, Izanne, Butzkueven, Helmut, van der Walt, Anneke, & Sormani, Maria Pia. (2024). Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry. Journal of Neurology, Neurosurgery and Psychiatry, null. https://doi.org/10.1136/jnnp-2023-332603

Wang, Angela A., Luessi, Felix, Neziraj, Tradite, Pössnecker, Elisabeth, Zuo, Michelle, Engel, Sinah, Hanuscheck, Nicholas, Florescu, Alexandra, Bugbee, Eryn, Ma, Xianjie I., Rana, Fatima, Lee, Dennis, Ward, Lesley A., Kuhle, Jens, Himbert, Johannes, Schraad, Muriel, van Puijenbroek, Erwin, Klein, Christian, Urich, Eduard, et al. (2024). B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans. Science Translational Medicine, 16. https://doi.org/10.1126/scitranslmed.adi0295

Zuo, Michelle, Fettig, Naomi M., Bernier, Louis-Philippe, Pössnecker, Elisabeth, Spring, Shoshana, Pu, Annie, Ma, Xianjie I., Lee, Dennis Sw, Ward, Lesley A., Sharma, Anshu, Kuhle, Jens, Sled, John G., Pröbstel, Anne-Katrin, MacVicar, Brian A., Osborne, Lisa C., Gommerman, Jennifer L., & Ramaglia, Valeria. (2024). Erratum: Age-dependent gray matter demyelination is associated with leptomeningeal neutrophil accumulation (JCI insight PII: e183445). JCI Insight, 9. https://doi.org/10.1172/jci.insight.183445

Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis [Journal-article]. JAMA Neurology, 80(12), 1317. https://doi.org/10.1001/jamaneurol.2023.3997

Disanto, Giulio, Villa, Michele, Maleska Maceski, Aleksandra, Prosperetti, Chiara, Gobbi, Claudio, Kuhle, Jens, Cassina, Tiziano, & Agazzi, Pamela. (2023). Longitudinal serum neurofilament light kinetics in post‐anoxic encephalopathy [Journal-article]. Annals of Clinical and Translational Neurology, 10(12), 2407–2412. https://doi.org/10.1002/acn3.51903

Leone, Maurizio A., Gelati, Maurizio, Profico, Daniela C., Gobbi, Claudio, Pravatà, Emanuele, Copetti, Massimiliano, Conti, Carlo, Abate, Lucrezia, Amoruso, Luigi, Apollo, Francesco, Balzano, Rosario F., Bicchi, Ilaria, Carella, Massimo, Ciampini, Alessandro, Colosimo, Carlo, Crociani, Paola, D’Aloisio, Giada, Di Viesti, Pietro, Ferrari, Daniela, et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis [Journal-article]. Cell Stem Cell, 30(12), 1597–1609. https://doi.org/10.1016/j.stem.2023.11.001

Müller, Jannis, Cagol, Alessandro, Lorscheider, Johannes, Tsagkas, Charidimos, Benkert, Pascal, Yaldizli, Özgür, Kuhle, Jens, Derfuss, Tobias, Sormani, Maria Pia, Thompson, Alan, Granziera, Cristina, & Kappos, Ludwig. (2023). Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis [Journal-article]. JAMA Neurology, 80(11), 1232. https://doi.org/10.1001/jamaneurol.2023.3331

Sharmin, Sifat, Roos, Izanne, Simpson-Yap, Steve, Malpas, Charles, Sánchez, Marina M., Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva K., Patti, Francesco, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Boz, Cavit, Zakaria, Magd, Onofrj, Marco, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Prat, Alexandre, Girard, Marc, et al. (2023). The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Brain, 146(11), 4633–4644. https://doi.org/10.1093/brain/awad218

Callegari, I., Oechtering, J., Schneider, M., Perriot, S., Mathias, A., Voortman, M. M., Cagol, A., Lanner, U., Diebold, M., Holdermann, S., Kreiner, V., Becher, B., Granziera, C., Junker, A., Du Pasquier, R., Khalil, M., Kuhle, J., Kappos, L., Sanderson, N., & Derfuss, T. (2023). Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5 [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.09.29.560121

Harding-Forrester, Sam, Roos, Izanne, Nguyen, Ai-Lan, Malpas, Charles B, Diouf, Ibrahima, Moradi, Nahid, Sharmin, Sifat, Izquierdo, Guillermo, Eichau, Sara, Patti, Francesco, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand’Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, et al. (2023). Disability accrual in primary and secondary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(9), 707–717. https://doi.org/10.1136/jnnp-2022-330726

Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, Kuhle, Jens, Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, & Herman, Ann E. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials. eBioMedicine, 93. https://doi.org/10.1016/j.ebiom.2023.104662

Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, Kuhle, Jens, Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, & Herman, Ann E. (2023). Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials [Journal-article]. eBioMedicine, 93, 104662. https://doi.org/10.1016/j.ebiom.2023.104662

Andreasson U, Gobom J, Delatour V, Auclair G, Noam Y, Lee S, Wen J, Jeromin A, Arslan B, Maceski A, Willemse E, Zetterberg H, Kuhle J, & Blennow K. (2023). Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood. Clinical Chemistry and Laboratory Medicine, 61(7), 1245–1254. https://doi.org/10.1515/cclm-2022-1181

Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Barakovic, Muhamed, Amann, Michael, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, Kuhle, Jens, Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis. Multiple Sclerosis Journal, 29(6), 702–718. https://doi.org/10.1177/13524585221139152

Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Barakovic, Muhamed, Amann, Michael, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, Kuhle, Jens, Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis [Journal-article]. Multiple Sclerosis Journal, 29(6), 702–718. https://doi.org/10.1177/13524585221139152

Cagol A., Fuertes N.C., Stoessel M., Barakovic M., Schaedelin S., D’Souza M, Wurfel J., Brandt A.U., Kappos L., Sprenger T, Naegelin Y, Kuhle J, Granziera C, & Papadopoulou A. (2023). Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis. Journal of Neurology, 270(4), 2139–2148. https://doi.org/10.1007/s00415-022-11535-8

Margraf NG, Dargvainiene J, Theel E, Leypoldt F, Lieb W, Franke A, Berger K, Kuhle J, & Kuhlenbaeumer G. (2023). Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus. Journal of Neurology, 270(4), 2128–2138. https://doi.org/10.1007/s00415-022-11547-4

Vermunt, L., Sutphen, C., Dicks, E., de Leeuw, D. M., Allegri, R., Berman, S. B., Cash, D. M., Chhatwal, J. P., Cruchaga, C., Day, G., Ewers, M., Farlow, M., Fox, N. C., Ghetti, B., Graff-Radford, N., Hassenstab, J., Jucker, M., Karch, C. M., Kuhle, J., et al. (2023). Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.03.21.23287468

Kuhle J, Chitnis T., Banwell B., Tardieu M., Arnold DL, Rawlings A.M., Geertsen S.S., Lublin AL, Saubadu S., Truffinet P., & Kappos L. (2023). Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial. Multiple Sclerosis Journal, 29(3), 385–394. https://doi.org/10.1177/13524585221144742

Montalban X, Matthews PM, Simpson A, Petrie JL, Sammon C, Ramagopalan S, Disanto G, & Kuhle J. (2023). Real-world evaluation of ocrelizumab in multiple sclerosis: A systematic review. Annals of Clinical and Translational Neurology, 10(3), 302–311. https://doi.org/10.1002/acn3.51732

Tsagkas, Charidimos, Huck-Horvath, Antal, Cagol, Alessandro, Haas, Tanja, Amann, Michael, Barakovic, Muhamed, Ruberte, Esther, Melie-Garcia, Lester, Weigel, Matthias, Pezold, Simon, Schlaeger, Regina, Kuhle, Jens, Sprenger, Till, Kappos, Ludwig, Bieri, Oliver, Cattin, Philippe, Granziera, Cristina, & Parmar, Katrin. (2023). Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis [Journal-article]. Multiple Sclerosis and Related Disorders, 71, 104545. https://doi.org/10.1016/j.msard.2023.104545

Tsagkas C, Huck-Horvath A, Cagol A, Haas T, Amann M, Barakovic M, Ruberte E, Melie-Garcia L, Weigel M, Pezold S, Schlaeger R, Kuhle J, Sprenger T, Kappos L, Bieri O, Cattin P, Granziera C, & Parmar K. (2023). Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis. Multiple Sclerosis and Related Disorders, 71, 104545. https://doi.org/10.1016/j.msard.2023.104545

Telser, J., Grossmann, K., Weideli, O. C., Hillmann, D., Aeschbacher, S., Wohlwend, N., Velez, L., Kuhle, J., Maleska, A., Benkert, P., Risch, C., Conen, D., Risch, M., & Risch, L. (2023, February 16). The role of serum brain injury biomarkers in individuals with a mild-to-moderate COVID infection and Long-COVID - results from the prospective population-based COVI-GAPP study [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.02.15.23285972

Wenger A.L., Barakovic, Muhamed, Bosticardo, Sara, Schaedelin, Sabine, Daducci, Alessandro, Schiavi, Simona, Weigel, Matthias, Rahmanzadeh, Reza, Lu, Po-Jui, Cagol, Alessandro, Kappos, Ludwig, Kuhle, Jens, Calabrese, Pasquale, & Granziera, Cristina. (2023). An investigation of the association between focal damage and global network properties in cognitively impaired and cognitively preserved patients with multiple sclerosis. Frontiers in Neuroscience, 17. https://doi.org/10.3389/fnins.2023.1007580

Abu-Rumeileh S, Abdelhak A, Foschi M, D’Anna L, Russo M, Steinacker P, Kuhle J, Tumani H, Blennow K, & Otto M. (2023). The multifaceted role of neurofilament light chain protein in non-primary neurological diseases. Brain, 146(2), 421–437. https://doi.org/10.1093/brain/awac328

Spelman T, Ozakbas S, Alroughani R, Terzi M, Hodgkinson S, Laureys G, Kalincik T, Van Der Walt A, Yamout B, Lechner-Scott J, Soysal A, Kuhle J, Sanchez-Menoyo JL, Blanco Morgado Y, Spitaleri D, van Pesch V, Horakova D, Ampapa R, Patti F, et al. (2023). Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry. Multiple Sclerosis Journal, 29(2), 221–235. https://doi.org/10.1177/13524585221137502

Kyng KJ, Wellmann S, Lehnerer V, Hansen LH, Kuhle J, & Henriksen TB. (2023). Neurofilament Light Chain serum levels after Hypoxia-Ischemia in a newborn piglet model. Frontiers in Pediatrics, 10, 1068380. https://doi.org/10.3389/fped.2022.1068380

Abdelhak, Ahmed, Barba, Lorenzo, Romoli, Michele, Benkert, Pascal, Conversi, Francesco, D’Anna, Lucio, Masvekar, Ruturaj R., Bielekova, Bibiana, Prudencio, Mercedes, Petrucelli, Leonard, Meschia, James F., Erben, Young, Furlan, Roberto, De Lorenzo, Rebecca, Mandelli, Alessandra, Sutter, Raoul, Hert, Lisa, Epple, Varenka, Marastoni, Damiano, et al. (2023). Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis. Journal of Neurology, 270(7), 3315–3328. https://doi.org/10.1007/s00415-023-11768-1

Abdelhak, Ahmed, Benkert, Pascal, Schaedelin, Sabine, Boscardin, W. John, Cordano, Christian, Oechtering, Johanna, Ananth, Kirtana, Granziera, Cristina, Melie-Garcia, Lester, Montes, Shivany Condor, Beaudry-Richard, Alexandra, Achtnichts, Lutz, Oertel, Frederike C., Lalive, Patrice H., Leppert, David, Müller, Stefanie, Henry, Roland G., Pot, Caroline, Matthias, Amandine, et al. (2023). Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. JAMA Neurology, 80, 1317–1325. https://doi.org/10.1001/jamaneurol.2023.3997

Abdelhak, Ahmed, Kuhle, Jens, & Green, Ari J. (2023). Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain. JAMA Neurology, 80, 542–543. https://doi.org/10.1001/jamaneurol.2023.0394

Abdelhak, Ahmed, Petermeier, Franziska, Benkert, Pascal, Schädelin, Sabine, Oechtering, Johanna, Maleska Maceski, Aleksandra, Kabesch, Michael, Geis, Tobias, Laub, Otto, Leipold, Georg, Gobbi, Claudio, Zecca, Chiara, Green, Ari, Tumani, Hayrettin, Willemse, Eline, Wiendl, Heinz, Granziera, Cristina, Kappos, Ludwig, Leppert, David, et al. (2023). Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study. The Lancet Neurology, 22, 826–833. https://doi.org/10.1016/s1474-4422(23)00210-7

Achtnichts, Lutz, Zecca, Chiara, Findling, Oliver, Kamm, Christian P, Mueller, Stefanie, Kuhle, Jens, Lutterotti, Andreas, Gobbi, Claudio, Viviani, Camille, Villiger-Borter, Emanuela, & Nedeltchev, Krassen. (2023). Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: Primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS). BMJ Neurology Open, 5. https://doi.org/10.1136/bmjno-2022-000304

Amrein, Melissa, Meier, Stephanie, Schäfer, Ibrahim, Schaedelin, Sabine, Willemse, Eline, Benkert, Pascal, Walter, Joan, Puelacher, Christian, Zimmermann, Tobias, Median, Daniela, Egli, Caroline, Leppert, David, Twerenbold, Raphael, Zellweger, Michael, Kuhle, Jens, & Mueller, Christian. (2023). Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomes. Biomarkers, 28, 341–351. https://doi.org/10.1080/1354750x.2023.2172211

Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Lipps, Patrick, Cagol, Alessandro, Cerdá-Fuertes, Nuria, Neziraj, Tradite, Flammer, Julia, Lerner, Jasmine, Lecourt, Anne-Catherine, De Oliveira S. Siebenborn, Nina, Cortese, Rosa, Schaedelin, Sabine, Andreoli Schoeps, Vinicius, De Moura Brasil Matos, Aline, Trombini Mendes, Natalia, Dos Reis Pereira, Clarissa, Ribeiro Monteiro, Mario Luiz, Dos Apóstolos-Pereira, Samira Luisa, Schindler, Patrick, et al. (2023). Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients with Central Nervous System Demyelination. JAMA Neurology, 80, 989–995. https://doi.org/10.1001/jamaneurol.2023.2523

Bavato, Francesco, Kexel, Ann-Kathrin, Kluwe-Schiavon, Bruno, Maceski, Aleksandra, Baumgartner, Markus R., Seifritz, Erich, Kuhle, Jens, & Quednow, Boris B. (2023). A Longitudinal Investigation of Blood Neurofilament Light Chain Levels in Chronic Cocaine Users. Molecular Neurobiology, 60, 3935–3944. https://doi.org/10.1007/s12035-023-03327-6

Brousse, Mehdi, Delaby, Constance, De La Cruz, Elisa, Kuhle, Jens, Benkert, Pascal, Mondesert, Etienne, Ginestet, Nelly, Hirtz, Christophe, Camu, William, Lehmann, Sylvain, & Esselin, Florence. (2023). Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis. European Journal of Neurology, 30, 1919–1927. https://doi.org/10.1111/ene.15813

Buchmann, Arabella, Pirpamer, Lukas, Pinter, Daniela, Voortman, Margarete, Helmlinger, Birgit, Pichler, Alexander, Maceski, Aleksandra Maleska, Benkert, Pascal, Bachmaier, Gerhard, Ropele, Stefan, Reindl, Markus, Leppert, David, Kuhle, Jens, Enzinger, Christian, & Khalil, Michael. (2023). High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis. European Journal of Neurology, 30, 1389–1399. https://doi.org/10.1111/ene.15742

Butzkueven, Helmut, Hillert, Jan, Soilu-Hänninen, Merja, Ziemssen, Tjalf, Kuhle, Jens, Wergeland, Stig, Magyari, Melinda, Berger, Joseph R., Moore, Nicholas, Aydemir, Aida, Bezemer, Irene, & Sabidó, Meritxell. (2023). The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis. Current Medical Research and Opinion, 39, 1367–1374. https://doi.org/10.1080/03007995.2023.2256220

Callegari, Ilaria, Schneider, Mika, Aebischer, Vera, Voortman, Margarete M., Proschmann, Undine, Ziemssen, Tjalf, Lindberg, Raija, Fischer-Barnicol, Bettina, Khalil, Michael, Kappos, Ludwig, Kuhle, Jens, Sanderson, Nicholas S.R., & Derfuss, Tobias. (2023). Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders, 16. https://doi.org/10.1177/17562864221150040

Cerdá-Fuertes, Nuria, Nagy, Sara, Schaedelin, Sabine, Sinnecker, Tim, Ruberte, Esther, Papadopoulou, Athina, Würfel, Jens, Kuhle, Jens, Yaldizli, Özgür, Kappos, Ludwig, Derfuss, Tobias, & Décard, Bernhard F. (2023). Evaluation of frequency, severity, and independent risk factors for recurrence of disease activity after fingolimod discontinuation in a large real-world cohort of patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders, 16. https://doi.org/10.1177/17562864221150312

Cerdá-Fuertes, Nuria, Stoessel, Marc, Mickeliunas, Gintaras, Pless, Silvan, Cagol, Alessandro, Barakovic, Muhamed, Maceski, Aleksandra Maleska, Álvarez González, Cesar, D’ Souza, Marcus, Schaedlin, Sabine, Benkert, Pascal, Calabrese, Pasquale, Gugleta, Konstantin, Derfuss, Tobias, Sprenger, Till, Granziera, Cristina, Naegelin, Yvonne, Kappos, Ludwig, Kappos, Ludwig, et al. (2023). Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Multiple Sclerosis Journal, 29, 1540–1550. https://doi.org/10.1177/13524585231198760

Chen, Xinjie, Schädelin, Sabine, Lu, Po-Jui, Ocampo-Pineda, Mario, Weigel, Matthias, Barakovic, Muhamed, Ruberte, Esther, Cagol, Alessandro, Marechal, Benedicte, Kober, Tobias, Kuhle, Jens, Kappos, Ludwig, Melie-Garcia, Lester, & Granziera, Cristina. (2023). Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients. NeuroImage: Clinical, 37. https://doi.org/10.1016/j.nicl.2023.103349

Daruwalla, Cyrus, Shaygannejad, Vahid, Ozakbas, Serkan, Havrdova, Eva Kubala, Horakova, Dana, Alroughani, Raed, Boz, Cavit, Patti, Francesco, Onofrj, Marco, Lugaresi, Alessandra, Eichau, Sara, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem, Khoury, Samia J, Sajedi, Seyed Aidin, Turkoglu, Recai, Altintas, Ayse, et al. (2023). Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 29, 875–883. https://doi.org/10.1177/13524585231151951

Disanto, Giulio, Villa, Michele, Maleska Maceski, Aleksandra, Prosperetti, Chiara, Gobbi, Claudio, Kuhle, Jens, Cassina, Tiziano, & Agazzi, Pamela. (2023). Longitudinal serum neurofilament light kinetics in post-anoxic encephalopathy. Annals of Clinical and Translational Neurology, 10, 2407–2412. https://doi.org/10.1002/acn3.51903

Geis, Tobias, Gutzeit, Svena, Fouzas, Sotiris, Ambrosch, Andreas, Benkert, Pascal, Kuhle, Jens, & Wellmann, Sven. (2023). Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases. European Journal of Paediatric Neurology, 45, 9–13. https://doi.org/10.1016/j.ejpn.2023.05.003

Hamza, Tasnim, Chalkou, Konstantina, Pellegrini, Fabio, Kuhle, Jens, Benkert, Pascal, Lorscheider, Johannes, Zecca, Chiara, Iglesias-Urrutia, Cynthia P., Manca, Andrea, Furukawa, Toshi A., Cipriani, Andrea, & Salanti, Georgia. (2023). Synthesizing cross-design evidence and cross-format data using network meta-regression. Research Synthesis Methods, 14, 283–300. https://doi.org/10.1002/jrsm.1619

Herrera-Rivero, Marisol, Hofer, Edith, Maceski, Aleksandra, Leppert, David, Benkert, Pascal, Kuhle, Jens, Schmidt, Reinhold, Khalil, Michael, Wiendl, Heinz, Stoll, Monika, & Berger, Klaus. (2023). Evidence of polygenic regulation of the physiological presence of neurofilament light chain in human serum. Frontiers in Neurology, 14. https://doi.org/10.3389/fneur.2023.1145737

Ihalapathirana, Anusha, Chalkou, Konstantina, Siirtola, Pekka, Tamminen, Satu, Chandra, Gunjan, Benkert, Pascal, Kuhle, Jens, Salanti, Georgia, & Röning, Juha. (2023). Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients. Informatics in Medicine Unlocked, 42. https://doi.org/10.1016/j.imu.2023.101349

Kalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S., Atkins, Harold, Burman, Joachim, Massey, Jennifer, Sutton, Ian, Withers, Barbara, MacDonell, Richard, Grigg, Andrew, Torkildsen, Øivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva Kubala, Krasulova, Eva, Trněný, Marek, Kozak, Tomas, Van Der Walt, Anneke, et al. (2023). Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 80, 702–713. https://doi.org/10.1001/jamaneurol.2023.1184

Kiss, Máté G., Mindur, John E., Yates, Abi G., Lee, Donghoon, Fullard, John F., Anzai, Atsushi, Poller, Wolfram C., Christie, Kathleen A., Iwamoto, Yoshiko, Roudko, Vladimir, Downey, Jeffrey, Chan, Christopher T., Huynh, Pacific, Janssen, Henrike, Ntranos, Achilles, Hoffmann, Jan D., Jacob, Walter, Goswami, Sukanya, Singh, Sumnima, et al. (2023). Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis. Immunity, 56, 1502–1514. https://doi.org/10.1016/j.immuni.2023.04.013

Körtvelyessy, Peter, Diekämper, Elena, Ruprecht, Klemens, Endres, Matthias, Stubbemann, Paula, Kurth, Florian, Graw, Jan Adriaan, Menk, Mario, Kuhle, Jens, & Wohlrab, Felix. (2023). Serum neurofilament light chain in COVID-19 and the influence of renal function. European Journal of Medical Research, 28. https://doi.org/10.1186/s40001-023-01375-1

Leone, Maurizio A., Gelati, Maurizio, Profico, Daniela C., Gobbi, Claudio, Pravatà, Emanuele, Copetti, Massimiliano, Conti, Carlo, Abate, Lucrezia, Amoruso, Luigi, Apollo, Francesco, Balzano, Rosario F., Bicchi, Ilaria, Carella, Massimo, Ciampini, Alessandro, Colosimo, Carlo, Crociani, Paola, D’Aloisio, Giada, Di Viesti, Pietro, Ferrari, Daniela, et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. Cell Stem Cell, 30, 1597–1609. https://doi.org/10.1016/j.stem.2023.11.001

Leppert, David, Watanabe, Mitsuru, Schaedelin, Sabine, Piehl, Fredrik, Furlan, Roberto, Gastaldi, Matteo, Lambert, Jeremy, Evertsson, Björn, Fink, Katharina, Matsushita, Takuya, Masaki, Katsuhisa, Isobe, Noriko, Kira, Jun-Ichi, Benkert, Pascal, Maceski, Aleksandra, Willemse, Eline, Oechtering, Johanna, Orleth, Annette, Meier, Stephanie, & Kuhle, Jens. (2023). Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94, 726–737. https://doi.org/10.1136/jnnp-2022-330796

Lipps, Patrick, Ayroza Galvão Ribeiro Gomes, Ana Beatriz, Kulsvehagen, Laila, Mutke, Matthias Anthony, Kuhle, Jens, Papadopoulou, Athina, & Pröbstel, Anne-Katrin. (2023). Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurology, 80, 1377–1379. https://doi.org/10.1001/jamaneurol.2023.3956

Loser, Valentin, Benkert, Pascal, Vicino, Alex, Lim Dubois Ferriere, Pansy, Kuntzer, Thierry, Pasquier, Jérôme, Maceski, Aleksandra, Kuhle, Jens, & Theaudin, Marie. (2023). Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis—A Swiss reference center experience. Journal of the Peripheral Nervous System, 28(1), 86–97. https://doi.org/10.1111/jns.12524

Meier, Stephanie, Willemse, Eline A.J., Schaedelin, Sabine, Oechtering, Johanna, Lorscheider, Johannes, Melie-Garcia, Lester, Cagol, Alessandro, Barakovic, Muhamed, Galbusera, Riccardo, Subramaniam, Suvitha, Barro, Christian, Abdelhak, Ahmed, Thebault, Simon, Achtnichts, Lutz, Lalive, Patrice, Müller, Stefanie, Pot, Caroline, Salmen, Anke, Disanto, Giulio, et al. (2023). Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis. JAMA Neurology, 80, 287–297. https://doi.org/10.1001/jamaneurol.2022.5250

Müller, Jannis, Cagol, Alessandro, Lorscheider, Johannes, Tsagkas, Charidimos, Benkert, Pascal, Yaldizli, Özgür, Kuhle, Jens, Derfuss, Tobias, Sormani, Maria Pia, Thompson, Alan, Granziera, Cristina, & Kappos, Ludwig. (2023). Harmonizing Definitions for Progression Independent of Relapse Activity inMultiple Sclerosis A Systematic Review. JAMA Neurology, 80, 1232–1245. https://doi.org/10.1001/jamaneurol.2023.3331

Müller, Jannis, Schädelin, Sabine, Lorscheider, Johannes, Benkert, Pascal, Hänni, Peter, Schmid, Jürg, Kuhle, Jens, Derfuss, Tobias, Granziera, Cristina, & Yaldizli, Özgür. (2023). Comparative analysis of dimethyl fumarate and teriflunomide in relapsing–remitting multiple sclerosis. European Journal of Neurology, 30, 3809–3818. https://doi.org/10.1111/ene.16044

Nittas, Vasileios, Zecca, Chiara, Kamm, Christian P., Kuhle, Jens, Chan, Andrew, & Wyl, Viktor Von. (2023). Digital health for chronic disease management: An exploratory method to investigating technology adoption potential. PLoS ONE, 18. https://doi.org/10.1371/journal.pone.0284477

Overeem, Lucas Hendrik, Raffaelli, Bianca, Fleischmann, Robert, Süße, Marie, Vogelgesang, Antje, Maceski, Aleksandra Maleska, Papadopoulou, Athina, Ruprecht, Klemens, Su, Wendy, Koch, Mirja, Siebert, Anke, Arkuszewski, Michal, Tenenbaum, Nadia, Kuhle, Jens, & Reuter, Uwe. (2023). Serum tau protein elevation in migraine: a cross-sectional case–control study. Journal of Headache and Pain, 24. https://doi.org/10.1186/s10194-023-01663-5

Roos, Izanne, Hughes, Stella, McDonnell, Gavin, Malpas, Charles B., Sharmin, Sifat, Boz, Cavit, Alroughani, Raed, Ozakbas, Serkan, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Lechner-Scott, Jeannette, Kuhle, Jens, Terzi, Murat, Laureys, Guy, Van Hijfte, Liesbeth, John, Nevin, Grammond, Pierre, et al. (2023). Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 80, 789–797. https://doi.org/10.1001/jamaneurol.2023.1625

Rosenkranz, Sina C., Gutmann, Lilija, Has Silemek, Arzu Ceylan, Dorr, Michael, Häußler, Vivien, Lüpke, Margareta, Mönch, Andrea, Reinhardt, Stefanie, Kuhle, Jens, Tilsley, Penelope, Heesen, Christoph, Friese, Manuel A., Brandt, Alexander, Paul, Friedemann, Zimmermann, Hanna, & Stellmann, Jan-Patrick. (2023). Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94, 924–933. https://doi.org/10.1136/jnnp-2023-331183